Finding Balance through Innovation

Dr. Ashley Ledbetter Dombkowski is Chief Business Officer and Vice
President of Operations at 23andMe, Inc. with responsibility for
business development, alliance management, operations, and finance.
She was previously a member of the Board of Directors at 23andMe and
was a Managing Director and member of the Investment Committee at MPM
Capital. During her years as a healthcare venture capitalist she
focused on developing innovative, entrepreneurial biotechnology and
medical device companies, including companies such as Alnara,
BioVitrum, Epizyme, Hemosense, iPierian, Neosil, Nevro, Rigel, and
Tercica. Prior to this, she was a Healthcare Equity Analyst for Tiger
Management and for Dresdner RCM Global Investors. Dr. Dombkowski
holds a PhD in mathematics from Rice University for work in partial
differential equations and geometric measure theory. She received her
BA in mathematics from Wellesley College where she was inducted into
the Sigma Xi Scientific Research Society and was awarded The Lewis
Atterbury Stimson Prize in Mathematics. She has been widely quoted in
both trade and national print publications ranging from Nature to The
Wall Street Journal and has appeared on CNBC, at TedMed, and as a
co-host of the World Health Forum. A member of the Wellesley College
Business Leadership Council, she was recognized as one of the 100 Most
Influential Women in Business by the San Jose/Silicon Valley Business
Journal in 2010.